» Articles » PMID: 23841803

Structure-guided Inhibitor Design Expands the Scope of Analog-sensitive Kinase Technology

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2013 Jul 12
PMID 23841803
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Engineered analog-sensitive (AS) protein kinases have emerged as powerful tools for dissecting phospho-signaling pathways, for elucidating the cellular function of individual kinases, and for deciphering unanticipated effects of clinical therapeutics. A crucial and necessary feature of this technology is a bioorthogonal small molecule that is innocuous toward native cellular systems but potently inhibits the engineered kinase. In order to generalize this method, we sought a molecule capable of targeting divergent AS-kinases. Here we employ X-ray crystallography and medicinal chemistry to unravel the mechanism of current inhibitors and use these insights to design the most potent, selective, and general AS-kinase inhibitors reported to date. We use large-scale kinase inhibitor profiling to characterize the selectivity of these molecules as well as examine the consequences of potential off-target effects in chemical genetic experiments. The molecules reported here will serve as powerful tools in efforts to extend AS-kinase technology to the entire kinome and the principles discovered may help in the design of other engineered enzyme/ligand pairs.

Citing Articles

MAPK Cascades in Plant Microbiota Structure and Functioning.

Van Gerrewey T, Chung H J Microbiol. 2024; 62(3):231-248.

PMID: 38587594 DOI: 10.1007/s12275-024-00114-3.


Eph receptors and ephrins in cancer progression.

Pasquale E Nat Rev Cancer. 2023; 24(1):5-27.

PMID: 37996538 PMC: 11015936. DOI: 10.1038/s41568-023-00634-x.


Strategy toward Kinase-Selective Drug Discovery.

Zhang M, Liu Y, Jang H, Nussinov R J Chem Theory Comput. 2023; 19(5):1615-1628.

PMID: 36815703 PMC: 10018734. DOI: 10.1021/acs.jctc.2c01171.


CDK9 and PP2A regulate RNA polymerase II transcription termination and coupled RNA maturation.

Tellier M, Zaborowska J, Neve J, Nojima T, Hester S, Fournier M EMBO Rep. 2022; 23(10):e54520.

PMID: 35980303 PMC: 9535751. DOI: 10.15252/embr.202154520.


Reactivity-based chemical-genetic study of protein kinases.

Miranda R, Zhang C RSC Med Chem. 2022; 13(7):783-797.

PMID: 35923719 PMC: 9298188. DOI: 10.1039/d1md00389e.


References
1.
McGovern S, Helfand B, Feng B, Shoichet B . A specific mechanism of nonspecific inhibition. J Med Chem. 2003; 46(20):4265-72. DOI: 10.1021/jm030266r. View

2.
Lampson M, Kapoor T . Unraveling cell division mechanisms with small-molecule inhibitors. Nat Chem Biol. 2006; 2(1):19-27. DOI: 10.1038/nchembio757. View

3.
Garske A, Peters U, Cortesi A, Perez J, Shokat K . Chemical genetic strategy for targeting protein kinases based on covalent complementarity. Proc Natl Acad Sci U S A. 2011; 108(37):15046-52. PMC: 3174669. DOI: 10.1073/pnas.1111239108. View

4.
Knight Z, Shokat K . Features of selective kinase inhibitors. Chem Biol. 2005; 12(6):621-37. DOI: 10.1016/j.chembiol.2005.04.011. View

5.
Bain J, Plater L, Elliott M, Shpiro N, Hastie C, McLauchlan H . The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007; 408(3):297-315. PMC: 2267365. DOI: 10.1042/BJ20070797. View